Anticancer 'nanoswitch' technology shows promise in animal model of triple-negative breast cancer, colorectal cancer

A probe squad led by Professor Yoosoo Yang (Department of Integrative Biotechnology) of Sungkyunkwan University, successful collaboration with the Korea Institute of Science and Technology (KIST) and Incheon National University, has developed a next-generation anticancer immunotherapy exertion that targets and eliminates cardinal substances released by crab cells portion simultaneously boosting the patient's immune response.